CEN/TC 206
Registration number (WIID) | Project No. | Title | Status |
---|---|---|---|
60725 | EN ISO 10993-18:2020 | Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process (ISO 10993-18:2020) | Standarts spēkā |
32004 | EN ISO 10993-18:2009 | Biological evaluation of medical devices - Part 18: Chemical characterization of materials (ISO 10993-18:2005) | Atcelts |
9500 | EN ISO 10993-18:2005 | Biological evaluation of medical devices - Part 18: Chemical characterization of materials (ISO 10993-18:2005) | Atcelts |
78994 | EN ISO 10993-17:2023/prA1 | Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents - Amendment 1 (ISO 10993-17:2023/DAmd 1:2024) | Aptauja slēgta |
67767 | EN ISO 10993-17:2023 | Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents (ISO 10993-17:2023) | Standarts spēkā |
32003 | EN ISO 10993-17:2009 | Biological evaluation of medical devices - Part 17: Establishment of allowable limits for leachable substances (ISO 10993-17:2002) | Atcelts |
9499 | EN ISO 10993-17:2002 | Biological evaluation of medical devices - Part 17: Establishment of allowable limits for leachable substances (ISO 10993-17:2002) | Atcelts |
60724 | EN ISO 10993-16:2017 | Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables (ISO 10993-16:2017) | Standarts spēkā |
30062 | EN ISO 10993-16:2010 | Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables (ISO/DIS 10993-16:2008) | Atcelts |
32002 | EN ISO 10993-16:2009 | Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables (ISO 10993-16:1997) | Atcelts |
Displaying 141-150 of 190 results.